LeonaBio, Inc.

LONA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Assets
Cash & Equivalents $69.3M $48.4M $90.6M $96.0M $110.5M $60.6M $2.1M
Accounts Receivable — — — — — — —
Inventory — — — — — — —
Total Current Assets $89.5M $54.8M $154.7M $207.5M $260.8M $192.3M $2.2M
Property, Plant & Equipment $1.5M $2.4M $3.4M $4.1M $3.8M $2.6M —
Goodwill — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — —
Total Assets $92.2M $58.8M $160.2M $258.2M $332.0M $279.6M $2.2M
Liabilities
Accounts Payable $4.6M $319.0K $129.0K $2.5M $567.0K $1.2M $421.0K
Total Current Liabilities $47.5M $13.1M $28.8M $21.4M $9.3M $4.4M $1.3M
Long-Term Debt — — — — — — —
Total Liabilities $64.4M $13.9M $30.1M $23.0M $10.9M $5.3M $4.9M
Stockholders' Equity
Retained Earnings $-511.8M $-406.1M $-309.2M $-191.5M $-95.9M $-41.0M $-21.1M
Total Stockholders' Equity $27.8M $44.8M $130.2M $235.1M $321.1M $274.3M $-19.7M